India records 2,58,089 new Covid infections including 8,209 Omicron cases, 385 deaths

India saw a single-day rise of 2,58,089 new coronavirus infections taking the tally of cases to 3,73,80,253, which included 8,209 cases of the Omicron variant detected so far, according to data updated by the Union Health Ministry on Monday.

A total of 8,209 cases of the Omicron variant have been detected across 29 states and union territories, out of which 3,109 have recovered or migrated. Maharashtra recorded the maximum 1,738 cases of the Omicron variant, followed by West Bengal 1,672, Rajasthan 1,276, Delhi 549, Karnataka 548 and Kerala 536 cases.

According to experts, it is not possible to undertake genome sequencing of each and every sample but this current wave is largely being driven by Omicron.

The number of active COVID-19 cases have increased to 16,56,341, the highest in around 230 days, while the death toll has climbed to 4,86,451 with 385 daily fatalities, the data updated at 8 am stated.

The active cases account for 4.43 per cent of the total infections, while the national COVID-19 recovery rate has decreased to 94.27 per cent, the ministry said.

An increase of 1,05,964 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

The daily positivity rate was recorded at 19.65 per cent, while the weekly positivity rate was 14.41 per cent, according to the ministry.

The number of people who have recuperated from the disease surged to 3,52,37,461, while the case fatality rate was recorded at 1.30 per cent.

The cumulative doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 157.20 crore.

India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 2020; 30 lakh on August 23; 40 lakh on September 5; and 50 lakh on September 16. It went past 60 lakh on September 28; 70 lakh on October 11; 80 lakh on October 29; 90 lakh on November 20; and surpassed the one-crore mark on December 19. India crossed the grim milestone of two crore infections on May 4 and three crore cases on June 23.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India